From: A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease
Model | Exposure | Outcome | R2 | nSNP | Method | β | SE | P-value |
---|---|---|---|---|---|---|---|---|
1 | GlycA | COPD | 2.30 | 9 | Inverse variance weighted | 0.001 | 0.027 | 0.97 |
Weighted median | −0.009 | 0.029 | 0.76 | |||||
Weighted mode | −0.028 | 0.039 | 0.49 | |||||
Simple mode | −0.013 | 0.046 | 0.79 | |||||
MR Egger | −0.140 | 0.147 | 0.37 | |||||
2 | COPD | GlycA | 1.72 | 8 | Inverse variance weighted | 0.306 | 0.090 | 0.00068 |
Weighted median | 0.348 | 0.115 | 0.0024 | |||||
Weighted mode | 0.378 | 0.150 | 0.04 | |||||
Simple mode | 0.359 | 0.157 | 0.06 | |||||
MR Egger | 0.412 | 0.624 | 0.53 |